Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088352608> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W3088352608 endingPage "1791" @default.
- W3088352608 startingPage "1786" @default.
- W3088352608 abstract "Background/aim: It is claimed that aberrant immune response has a more important role than the cytopathic effect of the virus in the morbidity and mortality of the coronavirus disease 2019 (COVID-19). We aimed to investigate the possible roles of tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/Fn14 pathway and leukotrienes (LT) in uncontrolled immune response that occurs in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Materials and methods: This study included 25 asymptomatic patients and 35 patients with lung involvement who were diagnosed with COVID-19 as well as 22 healthy volunteers. Lung involvement was determined using computed-tomography. Serum TWEAK, LTE4, and prostaglandin F2∝ (PGF2∝) levels were determined. Results: Compared with the healthy control group, TWEAK, LTE4, and PGF2∝ levels were higher in the group of SARS-CoV-2 infection without lung involvement. In the group of SARS-CoV-2 infection with lung involvement, age, fibrinogen, sedimentation, C-reactive protein and ferritin, TWEAK, LTE4, and PGF2∝ levels were higher, and lymphocyte levels were lower compared with the asymptomatic group. Conclusions: In the study, TWEAK and LTE4 levels increased in cases with COVID-19. These results support that TWEAK/Fn14 pathway and LT may involved in the pathology of aberrant immune response against SARS-CoV-2. Inhibition of each of these pathways may be a potential target in the treatment of COVID-19." @default.
- W3088352608 created "2020-10-01" @default.
- W3088352608 creator A5027746311 @default.
- W3088352608 creator A5029025262 @default.
- W3088352608 creator A5030264682 @default.
- W3088352608 creator A5043091484 @default.
- W3088352608 creator A5046127669 @default.
- W3088352608 creator A5064726798 @default.
- W3088352608 creator A5070539251 @default.
- W3088352608 creator A5088450399 @default.
- W3088352608 date "2020-12-17" @default.
- W3088352608 modified "2023-09-27" @default.
- W3088352608 title "The assessment of the serum levels of TWEAK and prostaglandin F2α in COVID – 19" @default.
- W3088352608 doi "https://doi.org/10.3906/sag-2006-96" @default.
- W3088352608 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7778458" @default.
- W3088352608 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32979900" @default.
- W3088352608 hasPublicationYear "2020" @default.
- W3088352608 type Work @default.
- W3088352608 sameAs 3088352608 @default.
- W3088352608 citedByCount "7" @default.
- W3088352608 countsByYear W30883526082021 @default.
- W3088352608 countsByYear W30883526082022 @default.
- W3088352608 countsByYear W30883526082023 @default.
- W3088352608 crossrefType "journal-article" @default.
- W3088352608 hasAuthorship W3088352608A5027746311 @default.
- W3088352608 hasAuthorship W3088352608A5029025262 @default.
- W3088352608 hasAuthorship W3088352608A5030264682 @default.
- W3088352608 hasAuthorship W3088352608A5043091484 @default.
- W3088352608 hasAuthorship W3088352608A5046127669 @default.
- W3088352608 hasAuthorship W3088352608A5064726798 @default.
- W3088352608 hasAuthorship W3088352608A5070539251 @default.
- W3088352608 hasAuthorship W3088352608A5088450399 @default.
- W3088352608 hasBestOaLocation W30883526081 @default.
- W3088352608 hasConcept C126322002 @default.
- W3088352608 hasConcept C203014093 @default.
- W3088352608 hasConcept C2777648638 @default.
- W3088352608 hasConcept C2777714996 @default.
- W3088352608 hasConcept C2777910003 @default.
- W3088352608 hasConcept C2779134260 @default.
- W3088352608 hasConcept C3008058167 @default.
- W3088352608 hasConcept C524204448 @default.
- W3088352608 hasConcept C71924100 @default.
- W3088352608 hasConcept C8891405 @default.
- W3088352608 hasConceptScore W3088352608C126322002 @default.
- W3088352608 hasConceptScore W3088352608C203014093 @default.
- W3088352608 hasConceptScore W3088352608C2777648638 @default.
- W3088352608 hasConceptScore W3088352608C2777714996 @default.
- W3088352608 hasConceptScore W3088352608C2777910003 @default.
- W3088352608 hasConceptScore W3088352608C2779134260 @default.
- W3088352608 hasConceptScore W3088352608C3008058167 @default.
- W3088352608 hasConceptScore W3088352608C524204448 @default.
- W3088352608 hasConceptScore W3088352608C71924100 @default.
- W3088352608 hasConceptScore W3088352608C8891405 @default.
- W3088352608 hasIssue "8" @default.
- W3088352608 hasLocation W30883526081 @default.
- W3088352608 hasLocation W30883526082 @default.
- W3088352608 hasLocation W30883526083 @default.
- W3088352608 hasOpenAccess W3088352608 @default.
- W3088352608 hasPrimaryLocation W30883526081 @default.
- W3088352608 hasRelatedWork W129423339 @default.
- W3088352608 hasRelatedWork W1987215768 @default.
- W3088352608 hasRelatedWork W1991129960 @default.
- W3088352608 hasRelatedWork W1995188757 @default.
- W3088352608 hasRelatedWork W2007817983 @default.
- W3088352608 hasRelatedWork W2016679923 @default.
- W3088352608 hasRelatedWork W2116001782 @default.
- W3088352608 hasRelatedWork W2943195325 @default.
- W3088352608 hasRelatedWork W4229900919 @default.
- W3088352608 hasRelatedWork W17604275 @default.
- W3088352608 hasVolume "50" @default.
- W3088352608 isParatext "false" @default.
- W3088352608 isRetracted "false" @default.
- W3088352608 magId "3088352608" @default.
- W3088352608 workType "article" @default.